CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Moberg Pharma AB (publ) Company Snapshot
Moberg Pharma AB (publ) operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Moberg Pharma AB (publ) with three other pharmaceutical manufacturers in Europe: Lavipharm SA of Greece (2016 sales of 31.14 million Euro [US$35.87 million] ), Horizon Discovery Group PLC of the United Kingdom (£24.07 million [US$31.35 million] of which 53% was Services), and Hvivo PLC which is also based in the United Kingdom (£19.85 million [US$25.85 million] of which 100% was Medical and Scientific Research).

Sales Analysis. Moberg Pharma AB (publ) reported sales of SEK 334.30 million (US$40.26 million) for the year ending December of 2016. This represents an increase of 17.1% versus 2015, when the company's sales were SEK 285.57 million. Sales at Moberg Pharma AB (publ) have increased during each of the previous five years (and since 2011, sales have increased a total of 498%). Sales of Kerasal saw an increase that was more than double the company's growth rate: sales were up 120.1% in 2016, from SEK 31.09 million to SEK 68.41 million. Moberg Pharma AB (publ) also saw significant increases in sales in Other Products (up 34.7% to SEK 82.06 million) . Not all segments of Moberg Pharma AB (publ) experienced an increase in sales in 2016: sales of Jointflex fell 55.2% to SEK 16.32 million. Moberg Pharma AB (publ) also experienced decreases in sales in Nalox/kerasal Nail, Sales of Prodcuts (down 3.7% to SEK 151.29 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Moberg Pharma AB (publ)
  Stock Performance Chart for Moberg Pharma AB (publ)
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 49.70
(Figures in Swedish Kronor)
1 Week 1.2%   13 Weeks 0.6%  
4 Weeks -4.9%   52 Weeks 23.9%  
 
Moberg Pharma AB (publ) Key Data:
  Ticker: MOB Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 334,304,000
(Year Ending Jan 2017).
Employees: 37
  Currency: Swedish Kronor Market Cap: 865,368,547
  Fiscal Yr Ends: December Shares Outstanding: 17,411,842
  Share Type: Aktie Closely Held Shares: 7,367,030
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.